PLAQUE PHARE TRIAL CARBONE DOUBLE OPTIQUE - SHERCO - 3780
![PLAQUE PHARE TRIAL CARBONE DOUBLE OPTIQUE - SHERCO - 3780](https://www.shercoraw.com/7081-thickbox_default/plaque-phare-trial-carbone-double-optique.jpg)
![](https://www.o-taket.com/72722-large_default/plaque-de-phare-origine-sherco-se-rsm-r-50125300-2013.jpg)
Plaque de phare origine SHERCO SE-R/SM-R 50/125/300 2013→ origine S
![](http://www.promotopieces.net/103-large_default/plateau-de-pression-embrayage-origine-moto-cross-honda-125-cr-je01e-52-1986-1999.jpg)
plateau-de-pression-embrayage-origine-moto-cross-honda-125-cr-je01e-52-1986-1999.jpg
![](https://www.dherbeymoto.com/marchand/images/diaporama/5f6afd3b069a6Reposes%20pieds%20CURVE-01.jpg)
Dherbey Moto - Site Marchand : Plaque phare SHERCO complete homologation noir
![](https://www.thelancet.com/cms/attachment/964d5316-ebd2-4bf8-818e-1ee87b2ac22b/gr3_lrg.gif)
6 months versus 12 months of adjuvant trastuzumab in early breast cancer ( PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial - The Lancet
![](https://acld.memberclicks.net/assets/Headshots/2021_Conference/DARBAR.png)
2021 ALD Abstracts
![](https://acld.memberclicks.net/assets/Headshots/2021_Conference/Harrison%20Jeffrey.png)
2021 ALD Abstracts
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13046-022-02415-0/MediaObjects/13046_2022_2415_Fig6_HTML.png)
Aberrant miR-874-3p/leptin/EGFR/c-Myc signaling contributes to nasopharyngeal carcinoma pathogenesis, Journal of Experimental & Clinical Cancer Research
![](https://www.thelancet.com/cms/asset/be4ec54a-792e-4f6d-84e2-c210e6593ef3/gr2.jpg)
6 months versus 12 months of adjuvant trastuzumab in early breast cancer ( PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial - The Lancet
![](https://www.sec.gov/Archives/edgar/data/1273636/000119312521280686/g183935g24u54.jpg)
10-K